CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: indexer who wrote (5)	6/5/1997 9:38:00 AM
From: Dr. John M. de Castro	of 666

CLTR is producing some nice clinical results lately but the stock hasn't yet responded see: biz.yahoo.com biz.yahoo.com With a market cap of less than $120MM and a product with outstanding phase II results in Phase III, IMO CLTR is significantly undervalued. The main reason for the undervaluation as best as I can tell is that IDPH has a program for NonHodgkins Lymphoma that is closer to market. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next